舜宇光學(02382.HK):附屬擬認購歌爾光學股權
舜宇光學(02382.HK)公布,集團若干成員公司與歌爾股份(002241.SZ)及歌爾光學訂立諒解備忘錄。
根據諒解備忘錄,訂約方同意進一步磋商,以就認購事項訂立最終協議,其主要條款包括當重組完成後,寧波奧來以其持有的上海奧來的全部股權作價出資認購歌爾光學的股權;及於認購事項完成後,寧波奧來將持有認購事項完成後的歌爾光學股權約33.33%。
舜宇光學表示,上海奧來多年來深耕晶圓級微納光學領域,並已建立堅實而具競爭力的基礎,擁有一支經驗豐富的技術人員團隊,配備先進的工具、設備及機械。倘落實認購事項,將促進上海奧來與歌爾光學的優勢互補,顯著增強在認購事項完成後歌爾光學在光波導及其他晶圓級微納光學器件等領域內的核心競爭力。
寧波奧來是舜宇浙江光學的全資附屬公司,舜宇浙江光學是舜宇光學的全資附屬公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.